Association of TLR4 gene polymorphism with susceptibility to and prognosis of hepatitis B virus-related primary liver cancer

He WeiLi; Yang XiaoYue; Zhang AiJun; Wang XiaoYang; Wang YaJun; Zhao Fan; Xu GuangFu

doi:10.3969/j.issn.1001-5256.2020.07.018

Volume 36 Issue 7

Jul. 2020

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2020 > 36(7): 1540-1544

PDF( 2155 KB)

Association of TLR4 gene polymorphism with susceptibility to and prognosis of hepatitis B virus-related primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2020.07.018

Department of Infectious Diseases, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China

Research funding:

Published Date: 2020-07-20

Abstract

Abstract

Objective To investigate the association of TLR4 gene polymorphism with the susceptibility to hepatitis B virus( HBV)-related primary liver cancer and its influence on the prognosis of patients. Methods A total of 106 patients with HBV-related liver cancer who were admitted to Beijing YouAn Hospital which cooperated with Dongzhimen Hospital of Beijing University of Chinese Medicine from June2015 to July 2017 were enrolled as liver cancer group; 120 patients with chronic hepatitis B who were admitted during the same period of time in Dongzhimen Hospital of Beijing University of Chinese Medicine were enrolled as hepatitis B group,and 100 healthy control subjects were enrolled as control group. Blood samples were collected from each group to detect TLR4 D299 G,T399 I,and A896 G polymorphisms,and postoperative recurrence was analyzed for liver cancer patients with different genotypes. An analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups;the chi-square test was used for comparison of categorical data between two groups,and the Kruskal-Wallis H test was used for comparison between multiple groups. An unconditional logistic regression model and odds ratio( OR) used to estimate relative risk were used to investigate the association of each factor with the onset risk of HBV-related primary liver cancer; the Kaplan-Meier curves were plotted for survival analysis,and the log-rank test was used for comparison of survival curves between groups. Results There were no significant differences in the genotype and allele distributions of TLR4 D299 G and TLR4 A896 G between the three groups( χ2= 1. 436,1. 949,1. 851,and2. 599,all P > 0. 05),while there were significant differences in the genotype and allele distributions of TLR4 T399 I between the three groups( χ2= 11. 654 and 14. 995,both P < 0. 05),and the liver cancer group had a significantly higher frequency of T allele than the hepatitis B group and the control group( P < 0. 05). The unconditional logistic regression model showed that CC genotype of TLR4 T399 I had an OR of 1. 682( 95% confidence interval[CI]: 1. 109-2. 243,P = 0. 027),TT genotype of TLR4 T399 I had an OR of 2. 103( 95% CI:1. 347-2. 896,P < 0. 001),and T allele of TLR4 T399 I had an OR of 1. 872( 95% CI: 1. 192-2. 374,P = 0. 002). There was no significant difference in recurrence-free survival after surgery between the liver cancer patients with different genotypes of TLR4 D299 G and TLR4 A896 G( χ2= 0. 022 and 0. 471,both P > 0. 05). The liver cancer patients with CC genotype of TLR4 T399 I had significantly better recurrence-free survival after surgery than those with CT or TT genotype( χ2= 6. 781,P < 0. 05). Conclusion TLR4 T399 I gene polymorphism is closely associated with the susceptibility to HBV-related primary liver cancer,and T gene of TLR4 T399 I may be an important factor for tumorigenesis and poor prognosis.
- Toll-like receptor 4,
- liver neoplasms,
- disease susceptibility,
- prognosis

FullText(HTML)

References(23)

References

[1]GAO JF,ZHANG H,LYU J,et al.Meta-analysis of the relationship between miRNA-196a-2 rs11614913 single nucleotide polymorphisms and the risk of primary hepatocellular carcinoma in Chinese population[J].Oncol Progr,2019,17(17):2011-2015.(in Chinese)高洁芳，张洪，吕舰，等．miRNA-196a-2 rs11614913单核苷酸多态性与中国人群中原发性肝细胞肝癌发病风险的Meta分析[J]．癌症进展，2019,17(17):2011-2015．

[2]CUI WH,LI CH,PIAO XX,et al.Relationship of Erb B2 gene rs1058808 polymorphism with HBV-related hepatocellular carcinoma in Yanbian area and ethnic difference[J].Shandong Med J,2017,57(10):5-7.(in Chinese)崔文豪，李成浩，朴熙绪，等．Erb B2基因rs1058808位点多态性与延边地区HBV相关肝细胞肝癌的关系及民族差异[J]．山东医药，2017,57(10):5-7．

[3]BAI LJ,YANG BS.Correlation of vascular endothelial growth factor634G/C and 2578C/A loci gene polymorphisms with chronic HBV infection of various clinical subtypes[J].Guangxi Med J,2018,40(20):2388-2391,2407.(in Chinese)柏立婧，杨宝山．血管内皮生长因子634G/C及2578C/A位点基因多态性与不同临床分型慢性HBV感染的相关性[J]．广西医学，2018,40(20):2388-2391,2407．

[4]LIU JJ,BIAN ZQ.Progress in genome-wide association of HBV related liver diseases[J].Int J Virol,2019,26(2):135-139.(in Chinese)刘娟娟，边中启．HBV相关肝病全基因组关联研究进展[J]．国际病毒学杂志，2019,26(2):135-139．

[5]ZHANG L,ZHANG L,ZHANG H,et al.Association between SMAD3 gene rs12901499 polymorphism and knee osteoarthritis in a Chinese population[J].J Clin Lab Anal,2018,32(5):e22383．

[6]OU WJ,LI YH,ZHOU Q,et al.Association of vitamin D-related gene polymorphisms with hepatitis B virus-related acute-on-chronic liver failure[J].J Clin Hepatol,2019,35(6):1308-1312.(in Chinese)欧伟杰，林烨鸿，周卿，等．维生素D相关基因单核苷酸多态性与HBV相关慢加急性肝衰竭的相关性分析[J]．临床肝胆病杂志，2019,35(6):1308-1312．

[7]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2015年更新版)[J]．临床肝胆病杂志，2015,31(12):1941-1960．

[8]HUANG CY,ZHANG H,BAI RD.The effects of TLR4 gene polymorphism on proliferation,migration and apoptosis of Hep G2 cells[J].J Mod Oncol,2017,25(22):3578-3582.(in Chinese)黄萃园，张洪，白瑞丹．TLR4基因多态性对肝癌细胞Hep G2增殖、迁移及凋亡的影响[J]．现代肿瘤医学，2017,25(22):3578-3582．

[9]SHEN Y,XIONG YG,ZHANG H.Relationship between polymorphism of TLR4896A>G and susceptibility of colorectal carcinoma:AMeta-analysis[J].Chin J Gastroenterol Hepatol,2018,27(12):1386-1392.(in Chinese)沈瑶，熊远果，张洪．TLR4基因多态性与结直肠癌易感性相关性Meta分析[J]．胃肠病学和肝病学杂志，2018,27(12):1386-1392．

[10]LI XC,WANG HW,LI CX.Present situation and prospect of comprehensive treatment of hepatocellular carcinoma[J].Chin J Dig Surg,2018,17(5):433-436.(in Chinese)李相成，王宏伟，李长贤．肝癌综合治疗的现状与展望[J]．中华消化外科杂志，2018,17(5):433-436．

[11]YANG WG,LI YH,XU H,et al.The Relationship between ERα-29gene polymorphisms and HBV-related hepatocellular carcinoma[J].Prog Mod Biomed,2016,16(30):5908-5910,5903.(in Chinese)杨伟国，李永红，徐辉，等．ERα-29位基因多态性与HBV相关原发性肝癌易感性的关系分析[J]．现代生物医学进展，2016,16(30):5908-5910,5903．

[12]VIDYANT S,CHATTERJEE A,AGARWAL V,et al.Susceptibility to HIV-1 infection is influenced by Toll like receptor-2(-196 to-174)polymorphism in North Indian population[J].J Gene Med,2017,19(8):e2971．

[13]HUANG CY,ZHANG H,BAI RD.Effect of TLR4 gene polymorphism on the treatment of liver cancer by sorafenib and its related molecular mechanisms[J].Chin J Hosp Pharm,2018,38(16):1712-1715.(in Chinese)黄萃园，张洪，白瑞丹，等．TLR4基因多态性对索拉菲尼治疗肝癌的影响及相关分子机制[J]．中国医院药学杂志，2018,38(16):1712-1715．

[14]XU GH,XU ZQ,HE J,et al.Relationship between ERα-29 polymorphism and HBV infection related primary liver cancer[J].Chin JGerontol,2018,38(2):371-373.(in Chinese)徐国辉，徐宗全，何均，等．ERα-29位多态性与HBV感染相关原发性肝癌的关系[J]．中国老年学杂志，2018,38(2):371-373．

[15]CHEN YL,SHOU LH,ZHANG ZX.Association of interleukin‐18gene polymorphism and its protein expression with the lower extremity deep venous thrombosis in the Chinese han population:A case-control study[J].J Clin Lab Anal,2018,32(4):e22345．

[16]CHEN C,TONG M,YAO WB,et al.Analysis of the relationship between gene polymorphism and the response of chronic hepatitis B patients to interferonα[J].Chin Med Biotechnol,2018,13(1):87-93.(in Chinese)陈晨，童梅，姚文兵，等．基因多态性与慢性乙肝患者对α干扰素应答的相关性分析[J]．中国医药生物技术，2018,13(1):87-93．

[17]YAN YX,ZHANG XB.The association between CD28 gene rs3116496 polymorphism and breast cancer risk in Chinese women[J].Biosci Rep,2017,37(6):BSR20170884．

[18]NI JM,HUANG L,WANG JF,et al.Study on the relationship between HBV resistance and liver cirrhosis and HCC[J].Chin Hepatol,2018,23(11):1024-1026.(in Chinese)倪俊明，黄玲，王建芳，等．肝硬化和肝细胞癌与HBV耐药关系探讨[J]．肝脏，2018,23(11):1024-1026．

[19]HANG SX,ZHANG PA,ZHAO YY.Association study between miRNA-221/222 polymorphism,liver function indicators and the risk of primary liver cancer[J].Chin J Integr Tradit West Med Liver Dis,2019,29(5):406-409.(in Chinese)韩竖霞，张平安，赵友云．miRNA-221/222基因多态性及肝功能指标与乙型肝炎病毒相关原发性肝癌的关联性研究[J]．中西医结合肝病杂志，2019,29(5):406-409．

[20]WANG H,WANG H,QIAO LJ.Study on p73 gene polymorphism and genetic susceptibility to hepatocellular cancer[J].Clin Med China,2017,33(3):236-241.(in Chinese)王亨，王慧，乔鲁军．p73基因多态性与原发性肝癌易感性的研究[J]．中国综合临床，2017,33(3):236-241．

[21]XU DM,XU JX.Analyzing for risk factors that affecting the survival time of patients with non-HBV and non-HCV affected hepatocellular carcinoma[J].Chin J Lab Diag,2018,22(8):1332-1335.(in Chinese)徐冬梅，徐江霞．影响非HBV和非HCV感染肝癌患者预后生存的风险因素分析[J]．中国实验诊断学，2018,22(8):1332-1335．

[22]GAO SQ,JIAO BH,HONG WX,et al.Distribution of KIR/HLA alleles among ethnic Han Chinese patients with hepatocellular carcinoma from southern China[J].Chin J Med Genetics,2019,36(5):439-442.(in Chinese)高素青，焦佰海，洪文旭，等．南方汉族肝癌患者KIR/HLA等位基因的分布特征[J]．中华医学遗传学杂志，2019,36(5):439-442．

[23]WANG M,CAI QE,WAN JY.Expression and significance of Toll like receptor 4 and toll like receptor 7 in placenta of pregnant women infected with hepatitis B virus[J].Matern Child Health Care China,2018,33(22):5254-5257.(in Chinese)王淼，蔡秋娥，万建玉．Toll样受体4和Toll样受体7在乙型肝炎病毒感染孕妇胎盘组织中的表达及意义[J]．中国妇幼保健，2018,33(22):5254-5257.

Relative Articles

[1]	Mingyue CHEN, Xiuliang ZHENG, Yaqin QIAO, Haitao SHEN, Yan LU. Effect of Toll-like receptor 4 on liver regeneration during acetaminophen-induced liver injury in mice[J]. Journal of Clinical Hepatology, 2023, 39(5): 1110-1118. doi: 10.3969/j.issn.1001-5256.2023.05.017
[2]	Linzhang ZHANG, Dingqi ZHANG, Ying XU, Hailin YANG, Shenglan QI, Congcong ZHANG, Jiamei CHEN, Ping LIU, Wei LIU. Cultured mycelia of Cordyceps sinensis exerts a protective effect on a mouse model of liver fibrosis by inhibiting the Toll-like receptor 4/nuclear transcription factor-κB signaling pathway and angiopoietin-like protein 4[J]. Journal of Clinical Hepatology, 2022, 38(7): 1540-1547. doi: 10.3969/j.issn.1001-5256.2022.07.016
[3]	Chenglong CHU, Chaohui TANG, Luyao XU, Changxu LI, Yingchao WANG. Association between Toll-like receptor 4 and pancreatic cancer[J]. Journal of Clinical Hepatology, 2021, 37(2): 485-488. doi: 10.3969/j.issn.1001-5256.2021.02.050
[4]	Gege TIAN, Enrui XIA, Suyan ZHANG, Shunzhen ZHAGN, Furong XU. Research advances in traditional Chinese medicine in improving nonalcoholic steatohepatitis by regulating the Toll-like receptor 4/nuclear factor-kappa B signaling pathway[J]. Journal of Clinical Hepatology, 2021, 37(12): 2957-2962. doi: 10.3969/j.issn.1001-5256.2021.12.047
[5]	Jing Jing, He TingTing, Wang RuiLin, Zhang Fan, Niu Ming, Guo YuMing, Zhu Yun, Xiao XiaoHe, Wang JiaBo. Detection of the risk signals of drug-induced liver injury: Challenges and advances[J]. Journal of Clinical Hepatology, 2020, 36(3): 491-496. doi: 10.3969/j.issn.1001-5256.2020.03.002
[6]	Cui HaiXia, Jin ChunMei, Wu ZhengXie, Jin AiHua, Zhang MeiLan. Correlation of miRNA-181c expression in peripheral blood mononuclear cells with interferon-γ,chemokine( C-X-C motif) ligand 10,and Toll-like receptor 4 in children with autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(10): 2236-2240. doi: 10.3969/j.issn.1001-5256.2020.10.015
[7]	Zheng Yang, Wang JiaRu, Liu LuLu, Wang JiaHui, Zhao TieJian. Molecular mechanism of the anti-liver fibrosis effect of curcumol: An analysis based on the TLR4/NF-κB signaling pathway[J]. Journal of Clinical Hepatology, 2020, 36(7): 1508-1513. doi: 10.3969/j.issn.1001-5256.2020.07.013
[8]	Li ShuZhi, Liu TieJun. Effect of Duxiao Ganqing Pill on liver inflammation in rats with cirrhotic endotoxemia: An analysis based on the TLR4/MyD88/NF-κB signaling pathway[J]. Journal of Clinical Hepatology, 2019, 35(9): 1958-1964. doi: 10.3969/j.issn.1001-5256.2019.09.015
[9]	Chen RuiLin, Shen QingYan, Niu KeMin, Yang ZhongTing, Yin XiuWen, Li Xue, Zhou Tao, Chen Jing, Wei BeiHai. Effect of the liver-regulating and spleen-strengthening method on the expression of Toll-like receptor 4 and occludin in the intestinal mucosa of rats with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(10): 2252-2256. doi: 10.3969/j.issn.1001-5256.2019.10.024
[10]	Huang Rong, Ni JiaJia, Gao Yi. The association between the intestinal microbiota-lipopolysaccharide-Toll-like receptor 4 axis and hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(6): 1325-1328. doi: 10.3969/j.issn.1001-5256.2018.06.041
[11]	Wang Yan, Cui LiJian, Xiao HongLi, Wang GuoXing, Yin ChengHong. Effect of angiotensin 1-7 on the TLR4/NF-κB pathway in cerulein-induced pancreatic acinar cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2146-2150. doi: 10.3969/j.issn.1001-5256.2016.11.029
[12]	Fan WenHai, Chen QingFeng. Research advances in association between Toll- like receptor 4 and hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(3): 584-587. doi: 10.3969/j.issn.1001-5256.2016.03.041
[13]	Wu YuJing, Guo JinSheng. Hepatic stellate cells,Toll-like receptor 4 signaling pathway,and inflammatory fibrotic microenvironment in the development of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(6): 876-879. doi: 10.3969/j.issn.1001-5256.2015.06.012
[14]	Liu Tao, Xu QiuLing, Zhao Yan. Expression of Toll-like receptor 4 in rat model of nonalcoholic fatty liver disease induced by hyperlipidemia[J]. Journal of Clinical Hepatology, 2015, 31(12): 2073-2076. doi: 10.3969/j.issn.1001-5256.2015.12.021
[15]	Shen Min, Fan HuaiYan, Wei Jia. Research progress in relationship between TLR4 and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(4): 630-634. doi: 10.3969/j.issn.1001-5256.2015.04.038
[16]	Tan GuoLei, Sun Mei, Wang JianFang, Wu XuPing. Relationship between IL- 28B polymorphisms and susceptibility to hepatitis C among Han population in Jiangsu Province, China[J]. Journal of Clinical Hepatology, 2014, 30(6): 514-517. doi: 10.3969/j.issn.1001-5256.2014.06.009
[17]	Yan ShuangHuan, Cao ZhiChen. Changes in Toll-like receptor 4 expression on the surface of peripheral blood monocytes in patients with chronic hepatitis B during interferon treatment [J]. Journal of Clinical Hepatology, 2012, 28(11): 828-830.
[18]	Jiang PingPing, Zhang Quan, Wang YuPing, Wang Hui, Cheng MingLiang. Preventive effects of blueberry on hepatic injury by downregulating the expression of TLR4[J]. Journal of Clinical Hepatology, 2012, 28(5): 380-382+394.
[19]	Gao Zhen, Zhang LunLi. Toll like receptors mediated innate immune responses against HBV infection[J]. Journal of Clinical Hepatology, 2011, 27(6): 667-669+673.
[20]	Wen Ming, Xiao XinQiang, Gong GuoZhong. Hepatitis C virus NS5A protein stimulates TLR4 expression[J]. Journal of Clinical Hepatology, 2011, 27(1): 49-52.

Supplements(0)

Cited By

Cited by

Periodical cited type(3)

1.	李慧，康纯嘉，董赛男，张心敏. TLR4和肠道菌群在原发性肝癌进展中动态变化及与其预后的关系. 实用癌症杂志. 2023(09): 1414-1417 .
2.	马臻杰，马兰，贾珍. 腹腔神经丛阻滞对大鼠肝部分切除术后应激反应和炎症因子的影响及其机制. 吉林大学学报(医学版). 2021(02): 407-413 .
3.	李欢，韩素桂，董宇曦. HBV相关原发性肝癌患者外周血MIF、GP73、VPIKA-Ⅱ的表达及意义. 国际检验医学杂志. 2021(10): 1171-1175 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1400) PDF downloads(138)

Association of TLR4 gene polymorphism with susceptibility to and prognosis of hepatitis B virus-related primary liver cancer

DOI: 10.3969/j.issn.1001-5256.2020.07.018